COVID-19 Clinical Update | March 2, 2022
Date of Presentation: March 2, 2022
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #covid #covid clinical updates #covid treatment
In this presentation, Dr. Jorge Mera, ECHO Medical Director and Director of Infectious Diseases for Cherokee Nation Health Services, discusses the latest COVID-19 clinical updates, mask guidance, variants, treatments and vaccine efficacy.
Recording:
Presented by:
Dr. Jorge Mera
Dr. Jorge Mera is the Director of Infectious Diseases for Cherokee Nation Health Services (CNHS), the largest tribally operated health care system in the United States. He completed his fellowship in Infectious Diseases and Clinical Microbiology at Baylor College of Medicine in Houston, Texas and is Board Certified by the American Board of Internal Medicine (ABIM) in Infectious Diseases. During recent years Jorge’s efforts have been dedicated to organizing the Cherokee Nation HCV elimination program, as well as the HIV/HCV ECHO project. He is also the Director of the HIV clinic since 2012 and the Principal Investigator of the End the HIV Epidemic for the CNHS. He is a Clinical Assistant Professor in the Department of Internal Medicine of the Oklahoma State University Health Science Center and a Fellow of the American College of Physicians.
Resources Provided:
- To Claim CE
- COVID-19 by County (CDC)
- Monitoring Variant Proportions (CDC)
- COVID-19 Treatment Guidelines (NIH)
- FDA authorizes revisions to Evusheld dosing (FDA)
- FDA Factsheet for Healthcare Providers: Evusheld EUA (FDA)
- FDA Factsheet for Healthcare Providers: Sotrovimab EUA (FDA)
- FDA Factsheet for Healthcare Providers: Molnupiravir EUA (FDA)
- FDA Factsheet for Healthcare Providers: Bebtelovimab EUA (FDA)
- Protection against the Omicron Variant from Previous SARS-CoV-2 Infection (NEJM)
- Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19 (NEJM)
- COVID-19 Drug Interaction Checker (Liverpool)
- COVID-19 Vaccines for Children and Teens (CDC)
- COVID-19: Vaccines (UpToDate)
- Interim Clinical Considerations for COVID-19 Vaccine in Children Ages 5–11 Years (CDC)
- bout the COVID-19 Vaccine: Frequently Asked Questions (AAP)
Date added: March 2, 2022